Nuevas estrategias neuro-oncológicas en el tratamiento de gliomas

Autores/as

  • Fabio H. Ottaviano FLENI, Buenos Aires, Argentina

DOI:

https://doi.org/10.47924/neurotarget2006412

Resumen

Nuevas estrategias neuro-oncológicas en el tratamiento de gliomas

Métricas

Cargando métricas ...

Citas

Brem S, Rozental JM, Moskal JR: What is the etiology of human brain tumors? A report of the first Lebow conference. Cancer 76: 709-713, 1995.

Briggs RJ, Fabinyi G, Kaye AH: Current management of acoustic neuromas: review of surgical approaches and outcomes. J Clin Neurosci 7: 521-26, 2000.

Cairncross JG, Ueki K, Zlatescu MC, et al.: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998; 90:1473–1479.

CBTRUS. 1996 Annual Report. Chicago: Central Brain Tumor Registry of the United States, 1997.

Chamberlain MC, Kormanik PA: Practical guidelines for the treatment of malignant gliomas. West J Med 168: 114-20, 1998.

Collins VP: Gliomas. Cancer Surv 32: 37-51, 1998.

Daumas-Duport C, Tucker M-L, Kolles H, et al.: Oligodendrogliomas: Part II—A new grading system based on morphological and imaging criteria. J Neurooncol 1997; 34:61–78,.

Daumas-Duport C, Varlet P, Tucker M-L, et al.: Oligodendrogliomas: Part 1—Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases. J Neurooncol 1997; 34:37–59.

Davis F, Freels S, Grutsch J, et al.: Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991. J Neurosurg 1998; 88:1–10,

De Angelis LM: Brain Tumors. NEJM 344: 114-123, 2001.

Engelhard HH: Gene therapy for brain tumors: The fundamentals. Surg Neurol 54: 3-9, 2000.

Fortin D, Cairncross GJ, Hammond RR: Oligodendroglioma: An appraisal of recent data pertaining to diagnosis and treatment. Neurosurgery 45: 1279-1291, 1999.

Forsyth PA, Roa WH. Primary central nervous system tumors in adults. Curr Treat Options Neurol 1: 377-394, 1999.

Gutin PH, Posner JB: Neuro-oncology: Diagnosis and management of cerebral gliomas. Past, present, and future. Neurosurgery 47: 2000.

Hakim R, Loeffler JS, Anthony DC, Black PM: Gangliogliomas in adults. Cancer 79: 127-31, 1997.

Hildebrand J, Dewitte O, Dietrich PY et al: Management of malignant brain tumors. Eur Neurol 38: 238-253, 1997.

Ino, Y., Zlatescu, MC., Sasaki, H., et al.: Long patient survival and therapeutic responses in histologically disparate high grade gliomas with chromosome 1p loss. J. Neurosurg., 2000; 92: 983–990,.

Ino Y., Betensky R., Zlatescu M. et al.: Molecular Subtypes of Anaplastic Oligodendroglioma: Implications for Patient Management at Diagnosis Clinical Cancer Research 2000;. 7: 839–845

Janny P, Cure H, Mohr M et al: Low grade supratentorial astrocitomas. Management andprognostic factors. Cancer 73: 1937-45, 1994.

Kaplan AM, Albright AL, Zimmerman RA et al: Brainstem Gliomas in Children. Pediatr Neurosurg 24: 185-192, 1996.

Kernohan JW, Maybon RF, Svien HJ, et al.: A simplified classification of the gliomas. Proc Staff Meet Mayo Clin 1949; 24:71–75,.

Kleihues and W. K. Cavenee (eds.), World Health Organization Classification of Tumours of the Central Nervous System. Lyon: IARC/ WHO, 2000.

Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system: World Health Organization Internal Histological Classification of Tumors. Berlin, Germany: Springer-Verlag, 1993.

Loiseau H: Prognosis of gliomas. Rev Neurol (Paris) 152: 84-102, 1996.

Louis DN: A molecular genetic model of astrocytoma histopathology. Brain Pathology 7: 755-764, 1997.

Louis DN, Gusella JF. A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 1995; 11:412-415.

Macdonald DR, Gaspar LE, Cairncross JG: Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 1990; 27:573– 574,.

McLendon, R. E., Enterline, D. S., Tien, R. D.et al.: Tumors of central neuroepithelial origin. In: D. D. Bigner, R. E. McLendon, and J. M. Bruner

Descargas

Publicado

2006-05-01

Cómo citar

1.
Ottaviano FH. Nuevas estrategias neuro-oncológicas en el tratamiento de gliomas. NeuroTarget [Internet]. 1 de mayo de 2006 [citado 22 de octubre de 2024];1(1):37-44. Disponible en: https://neurotarget.com/index.php/nt/article/view/412

Número

Sección

Original